Dato' Dr. Anas bin Alam Faizli has over 24 years of executive leadership experience across multiple industries, including pharmaceuticals, healthcare, oil and gas, heavy industry, asset management and renewable energy. He has held senior leadership and/or board positions in both public-listed companies and large private enterprises, with extensive experience in corporate strategy, governance, operational improvement and business transformation.

Most recently, he served as President and Chief Executive Officer of OCI TerraSus Sdn Bhd (2024-2025), a subsidiary of OCI Holdings Korea, where he led organisational restructuring, brand repositioning, IPO preparation initiatives and strengthened corporate governance frameworks. He also oversaw operational performance, safety management, ESG integration and business development initiatives in the semiconductor and green energy segments.

Prior to that, he was Chief Executive Officer, Corporate of Duopharma Biotech Berhad (2022-2024), where he contributed to the development of the company's 10-year ASEAN growth strategy, improved ESG performance metrics, strengthened safety standards and implemented cost optimisation initiatives.

Between 2020 and 2022, he served as Chief Executive Officer of ProtectHealth Corporation Sdn Bhd, leading Malaysia's largest public-private healthcare mobilisation during the COVID-19 vaccination rollout, coordinating over 4,000 vaccination centres and administering more than 38 million doses nationwide.

Earlier in his career, he held leadership roles at UEM Edgenta Berhad and Eversendai Corporation Berhad, and began his career with Talisman Malaysia, Petronas Carigali and Sime Sembcorp Engineering. He is known for his experience in corporate strategy, organisational transformation, governance strengthening and ESG-driven initiatives across regulated and asset-intensive industries.

Nil

No

No

Nil